A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists

CompletedOBSERVATIONAL

Enrollment

602

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)

Interventions

OTHER

No treatment given

Trial Locations (1)

Novo Nordisk Investigational Site, Bangalore